Ligand ID: ESL Drugbank ID: DB04573(Estriol) Indication:Used as a test to determine the general health of an unborn fetus. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 45ALA B 43LEU B 42GLY B 104LEU B 103 | 1.57A | 17.90 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 45LEU A 44ALA A 43GLY A 104LEU A 103 | 1.24A | 17.90 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 208LEU B 205ALA B 206ILE B 286LEU B 282 | 1.46A | 20.77 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 1uw7 | NSP9 (SARS-COVHKU-39849) | 5 / 12 | LEU A 29LEU A 44ALA A 43LEU A 42LEU A 106 | 1.48A | 19.84 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 205LEU A 208ALA A 206LEU A 253HIS A 246 | 1.57A | 21.09 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | LEU A 265LEU A 264ILE A 251GLY A 255LEU A 253 | 1.47A | 20.88 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | LEU H 96LEU D 60LEU D 64ILE H 112LEU H 103 | 1.53A | 21.46 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 5 / 12 | LEU C 15LEU C 13LEU C 49ARG C 48ILE C 20 | 1.62A | 13.41 | NoneNoneNoneNoneD10 C1099 ( 4.8A) | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 208LEU B 287ILE B 213LEU B 250 | 1.57A | 20.77 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 8 | TYR B 73ARG B 83HIS B 176LEU B 133 | 1.46A | 20.39 | NoneNoneSO4 B 320 (-3.9A)None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | MET A 170LEU A 173ALA A 177LEU A 133LEU A 124 | 1.43A | 22.77 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 4 / 8 | PHE X 19ALA Q 20HIS U 80LEU U 14 | 1.55A | 15.42 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 12 | LEU D 210ALA D 151LEU D 153ILE D 180GLY D 196 | 1.58A | 20.22 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2jw8 | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 5 / 12 | MET B 323LEU B 332ALA A 337ARG B 263GLY B 329 | 1.64A | 18.70 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 2kqv | NSP3 (SARSr-CoV) | 4 / 8 | PHE A 58ALA A 36LEU A 11MET A 25 | 1.55A | 19.17 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | MET A 218GLU A 210ARG A 198ILE A 235LEU A 227 | 1.50A | 21.88 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | MET D 209LEU D 299LEU D 297LEU D 250ILE D 306 | 1.48A | 21.88 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU F 250GLU F 210LEU F 298ARG F 198ILE F 322 | 1.35A | 21.41 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 8 | PHE F 213ARG F 198ALA F 255LEU F 248 | 1.59A | 21.96 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU F 250GLU F 210LEU F 298ARG F 198ILE F 322 | 1.38A | 21.41 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 2wct | NSP3 (SARSr-CoV) | 4 / 8 | TYR A 564PHE A 580ALA A 558LEU A 533 | 1.46A | 19.87 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU A 161ALA A 162LEU A 126GLY A 278LEU A 275 | 1.57A | 19.67 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU A 161ALA A 162LEU A 126GLY A 278LEU A 275 | 1.56A | 20.51 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLU B 406LEU B 410LEU B 370ILE B 291LEU B 439 | 1.36A | 17.88 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | PHE B 315ALA B 403HIS B 374MET B 376 | 1.56A | 20.55 | NoneNone ZN B 901 (-3.8A)None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 558ALA A 569LEU A 570GLY A 399HIS A 401 | 1.59A | 17.88 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 3e9s | NSP3 (SARSr-CoV) | 5 / 12 | MET A 170LEU A 173ALA A 177LEU A 133LEU A 124 | 1.55A | 23.53 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 3e9s | NSP3 (SARSr-CoV) | 4 / 8 | TYR A 137PHE A 128ALA A 145LEU A 118 | 1.42A | 19.96 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | MET D 101LEU C 103LEU C 106ALA C 107LEU D 9 | 1.63A | 18.11 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU D 67LEU D 89LEU D 75GLY D 29LEU D 27 | 1.54A | 20.77 | NoneNoneNoneNonePJE E 5 ( 4.1A) | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | MET B 170LEU B 173ALA B 177LEU B 133LEU B 124 | 1.31A | 23.29 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 3sci | ACE2 (Homosapiens) | 5 / 12 | LEU B 560ALA B 569GLU B 564LEU B 568GLY B 575 | 1.50A | 18.08 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLU B 406LEU B 410LEU B 370ILE B 291LEU B 439 | 1.41A | 18.08 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU B 560ALA B 569GLU B 564LEU B 568GLY B 575 | 1.40A | 18.08 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | PHE B 315ALA B 403HIS B 374MET B 376 | 1.61A | 20.77 | NoneNone ZN B 901 (-3.9A)None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 3to2 | BETA-2-MICROGLOBULINMHC CLASS I ANTIGEN (Homosapiens) | 4 / 8 | TYR A 7PHE A 9PHE B 56HIS A 114 | 1.48A | 20.26 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 205ALA A 206ILE A 286LEU A 282 | 1.55A | 20.12 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 8 | TYR A 73ARG A 83HIS A 176LEU A 133 | 1.42A | 21.24 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | MET A 170LEU A 173ALA A 177LEU A 133LEU A 124 | 1.45A | 23.63 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 4 / 8 | TYR B 137PHE B 128ALA B 145LEU B 118 | 1.44A | 20.17 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 4 / 6 | MET A 95VAL A 96PHE A 292MET A 118 | 1.63A | 20.65 | PO4 A 402 (-4.1A)OCS A 98 ( 4.2A)NoneNone | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 4 / 8 | TYR A 209ALA A 206HIS A 239LEU A 236 | 1.43A | 20.65 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 4wme | MERS-COV 3CLPROTEASE (MERS-CoV) | 4 / 6 | MET C 85LEU C 90PHE C 66MET C 43 | 1.49A | 20.36 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 5c5n | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 205ALA A 206ILE A 286LEU A 282 | 1.44A | 21.09 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | MET D 241VAL D 167LEU D 170PHE D 111 | 1.47A | 20.58 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 8 | TYR B 351PHE B 384HIS B 373LEU D 303 | 1.53A | 21.26 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | MET D 153LEU D 152ALA D 119LEU D 109GLY D 93 | 1.63A | 20.12 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | MET D 241VAL D 167LEU D 170PHE D 111 | 1.40A | 21.26 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 8 | TYR D 73ARG D 83HIS D 176LEU D 133 | 1.50A | 20.64 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | MET A 170LEU A 173ALA A 177LEU A 133LEU A 124 | 1.35A | 22.82 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5f22 | NSP8NSP7 (SARSr-CoV) | 5 / 12 | LEU B 96LEU A 60LEU A 64ILE B 112LEU B 103 | 1.51A | 21.32 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | MET C 153LEU C 152ALA C 119LEU C 109GLY C 93 | 1.55A | 19.88 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | MET B 170LEU B 173ALA B 177LEU B 133LEU B 124 | 1.33A | 23.53 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 8 | TYR B 73ARG B 83HIS B 176LEU B 133 | 1.46A | 20.39 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5x29 | ENVELOPE SMALLMEMBRANE PROTEIN (SARSr-CoV) | 5 / 12 | LEU E 39ALA E 43ARG A 38ILE E 33LEU E 31 | 1.53A | 20.99 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 5x29 | ENVELOPE SMALLMEMBRANE PROTEIN (SARSr-CoV) | 5 / 12 | LEU E 39ALA E 43ARG A 38ILE E 33LEU E 31 | 1.53A | 20.99 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5x4r | S PROTEIN (MERS-CoV) | 4 / 8 | TYR A 144PHE A 313ALA A 146LEU A 180 | 1.48A | 20.80 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | MET B 709LEU B1045LEU B 920GLY B 928LEU B 930 | 1.52A | 11.70 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | MET C1011VAL C1015LEU C1016PHE C 870 | 1.51A | 15.49 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5x59 | S PROTEIN (MERS-CoV) | 4 / 8 | TYR B 144PHE B 313ALA B 146LEU B 180 | 1.48A | 16.49 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | LEU B 265ALA B 182LEU B 149GLY B 262HIS B 264 | 1.48A | 11.12 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | MET A1011VAL A1015LEU A1016PHE A 870 | 1.41A | 16.85 | MET A1011 ( 0.0A)VAL A1015 ( 0.6A)LEU A1016 ( 0.6A)PHE A 870 ( 1.3A) | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5y3e | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | MET A 170LEU A 173ALA A 177LEU A 133LEU A 124 | 1.45A | 22.66 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 8 | TYR A 73ARG A 83HIS A 176LEU A 133 | 1.51A | 20.82 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.52A | 11.51 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU B 532LEU B 503ARG B 553ILE A 955GLY B 368 | 1.60A | 12.02 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | MET B1011VAL B1015LEU B1016PHE B 870 | 1.23A | 16.68 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6ack | ACE2 (Homosapiens) | 5 / 12 | GLU D 406LEU D 410LEU D 370ILE D 291LEU D 439 | 1.42A | 18.08 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | MET A1011VAL A1015LEU A1016PHE A 870 | 1.46A | 16.56 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | MET C1011VAL C1015LEU C1016PHE C 870 | 1.27A | 16.49 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B 846ALA B 754GLU B 755ILE A 650GLY A 298 | 1.56A | 11.95 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | LEU D 424MET D 297ILE D 307HIS D 373LEU D 370 | 1.57A | 18.20 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 8 | PHE C 909ARG C 887ALA C 864LEU C 788 | 1.58A | 16.49 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | ALA A 292LEU A 317ILE A 376GLY A 400LEU A 280 | 1.44A | 16.86 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6kl2 | NUCLEOPROTEIN (MERS-CoV) | 4 / 8 | TYR B 102PHE B 100PHE B 113ALA B 128 | 1.43A | 15.79 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6m17 | ACE2 (Homosapiens) | 4 / 8 | PHE B 715PHE B 724ALA B 650LEU D 642 | 1.55A | 19.36 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6m17 | ACE2 (Homosapiens) | 5 / 12 | LEU B 278LEU B 248LEU B 262GLY B 448LEU B 240 | 1.63A | 15.00 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 8 | PHE A 74ALA A 273LEU A 61MET A 71 | 1.32A | 21.64 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU A 494ALA A 498GLU A 501LEU A 85GLY A 272 | 1.30A | 18.49 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU A 494ALA A 498GLU A 501LEU A 85GLY A 272 | 1.23A | 18.49 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6m18 | ACE2 (Homosapiens) | 5 / 12 | ALA D 384MET D 557LEU D 554GLY D 395HIS D 401 | 1.41A | 15.00 | None | ||
![]() | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | MET A1011VAL A1015LEU A1016PHE A 870 | 1.20A | 16.51 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | LEU A 351ALA A 656LEU A 663GLY A 327HIS A 347 | 1.27A | 14.07 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | MET B 129LEU A 388ALA A 399LEU A 673MET A 668 | 1.40A | 21.89 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | LEU A 241LEU A 240ALA A 125GLY A 214LEU A 212 | 1.44A | 14.07 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6nus | NSP12 (SARSr-CoV) | 4 / 8 | TYR A 346PHE A 652HIS A 355LEU A 329 | 1.31A | 18.91 | None | ||
![]() | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | LEU A 558ALA A 569LEU A 570GLY A 399HIS A 401 | 1.62A | 17.88 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6vw1 | ACE2 (Homosapiens) | 4 / 8 | PHE B 315ALA B 403HIS B 374MET B 376 | 1.56A | 20.39 | None | ||
![]() | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | GLU B 406LEU B 410LEU B 370ILE B 291LEU B 439 | 1.34A | 17.88 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | TYR L 192PHE L 209ALA L 130LEU L 179 | 1.54A | 15.73 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 198PHE L 215ALA L 136LEU L 185 | 1.57A | 17.97 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 198PHE C 215ALA C 136LEU C 185 | 1.56A | 17.97 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR L 198PHE L 215ALA L 136LEU L 185 | 1.57A | 17.97 | None | ||
![]() | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR C 198PHE C 215ALA C 136LEU C 185 | 1.56A | 17.97 | None |